Cost-effectiveness of first-line immune checkpoint inhibitor therapies, alone or combined with targeted agents, for unresectable hepatocellular carcinoma in China: an economic evaluation using network meta-analysis
1. 系统已在2026-04-02 14:46:50对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/1750743X.2026.2647585
文献链接: https://www.tandfonline.com/doi/full/10.1080/1750743X.2026.2647585
其他信息:
出版社: Informa UK Limited
作者: Wei Li; Li Wan; Sijie He

